Music legend Sir Elton John lambasted the UK government's plans to exempt AI firms from copyright laws, allowing them to use artists' content without payment, calling it 'theft' and an 'incredible betrayal' that would rob young artists of their income.
House Republicans pushed a controversial bill imposing a decade-long freeze on state AI regulations, sparking concerns over potential erosion of consumer safeguards and states' ability to address AI risks like deepfakes and algorithmic bias.
Utah imposes stricter rules for mental health chatbots, mandating AI disclosure, prohibiting user data sales, limiting advertising, and extends its AI Policy Act until 2027 amid growing concerns over AI's impact.
House Republicans controversially proposed a decade-long federal ban on state oversight of AI systems, framing it as promoting innovation but drawing criticism as a 'gift to Big Tech' that disregards consumer privacy and enables deception.
ServiceNow launches its AI Control Tower, a real-time governance platform embedded in the Now Platform that tracks, audits, and enforces compliance across enterprise-wide AI models — including third-party systems — with tools for bias detection, explainability, drift monitoring, and regulatory alignment with GDPR and HIPAA.
AI pioneers faced tough questions about the Singularity, the disruptive potential of large language models, and AI's rapidly advancing coding abilities, sparking debates on the future impact of these technologies.
Over 400 music icons including Elton John, Dua Lipa, and Coldplay rallied for UK copyright reform to protect creators' rights, urging transparency and licensing regimes for AI developers using copyrighted material, arguing creative copyright is vital for the industry.
AI algorithms secretly influence what content people see online, shaping political views and social behavior, raising concerns over potential misuse for societal control by powerful entities, prompting calls for transparency and safeguards against dystopian outcomes.
OpenAI is in discussions with the FDA to explore leveraging AI, potentially through a project called cderGPT, to accelerate the drug approval process, with the FDA commissioner confirming the agency's first AI-assisted scientific review of a product.
Yale's Digital Ethics Center is collaborating with state lawmakers, scholars, tech leaders, and nonprofits to develop balanced AI regulations that foster innovation while safeguarding public interests, aiming to coordinate state-level policies in the absence of federal AI legislation.